Advances in the design and synthesis of isosteviol derivatives

Announcing a new publication for Acta Materia Medica journal. Isosteviol and its derivatives, diterpene compounds with a wide range of biological activities, play important antiviral, antibacterial, antioxidant, antitumor, analgesic, anti-inflammatory, antipyretic, antifungal, and anticardiovascular disease roles.

Numinus to Host Q2 Fiscal 2024 Results Conference Call on April 15, 2024 | Psychedelic Invest

VANCOUVER, BC, April 9, 2024 /CNW/ – Numinus Wellness Inc. (“Numinus” or the “Company”) (TSX: NUMI) (OTCQX: NUMIF), a mental health care company advancing traditional and innovative behavioural health

April 9, 2024

Novel method for ‘rationally engineering’ enzymes to deliver improved performance

Scientists have prototyped a new method for “rationally engineering” enzymes to deliver improved performance.

June 20, 2024

Europe issues maximum antitrust fine of $475 million to Illumina over Grail deal

LONDON — The European Union on Wednesday issued an antitrust fine of $475 million to the U.S. genetic sequencing giant Illumina for closing its acquisition

July 12, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.